Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma

Based on available data, most multiple myeloma patients have residual myeloma cells in their autologous hematopoietic progenitor cells (HPC) grafts during collection for autologous stemcell transplant. However, available literature is based on older induction regimens, e.g., adriamycin and dexametha...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Bone Marrow Transplant
Huvudupphovsmän: Tageja, Nishant, Korde, Neha, Kazandjian, Dickran, Manasanch, Elisabet, Bhutani, Manisha, Kwok, Mary, Mailankody, Sham, Yuan, Constance, Stetler-Stevenson, Maryalice, Leitman, Susan F., Sportes, Claude, Landgren, Ola
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6740327/
https://ncbi.nlm.nih.gov/pubmed/29728700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-018-0170-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk